Provectus Receives Indian Patent for Cancer Drug

Tennessee-based Provectus Pharmaceuticals has received a patent in India for its cancer drug PV-10.

The patent covers capsules, tablets, injectable formulations and oral suspensions and solutions, Provectus said.

The company is conducting Phase II trials on PV-10 as a treatment for melanoma and breast cancer.